Clinical Trials Directory

Trials / Unknown

UnknownNCT03480347

The BLF Early COPD Development Partnership Grant

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
30 Years – 45 Years
Healthy volunteers

Summary

Most existing medical research has focused on patients with well-established COPD and poor lung function. Whilst this is important because such patients have lots of symptoms and problems, in some respects a better way of reducing health problems in the future would be to develop a strategy which focuses on patients with milder disease, and identifies which ones will go on to develop more severe problems and why these problems occur. The research in this application is designed to investigate these issues. The main objective of the Partnership is to study the very early stages of the development of COPD. The investigators will do this by recruiting a novel cohort of smokers (age 30-45), in whom the investigators will follow the trajectories of lung function decline to identify prospectively those at risk of excess decline. This programme forms a unique UK consortium of 8 academic centres with excellent high quality publication records and broad experience in mechanistic, translational, clinical and epidemiological studies in COPD with key capabilities including primary care.

Conditions

Timeline

Start date
2018-01-17
Primary completion
2023-04-30
Completion
2023-04-30
First posted
2018-03-29
Last updated
2021-08-26

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03480347. Inclusion in this directory is not an endorsement.

The BLF Early COPD Development Partnership Grant (NCT03480347) · Clinical Trials Directory